General Anesthesia Drugs Market - More about Addressing Patient Safety Concerns

General Anesthesia Drugs Market Players Embrace R&D as Concerns over Side Effects Mount

  • 41 Tables
  • 75 Figures
  • 180 pages
  • PDF PPT EXCEL
General Anesthesia Drugs Consumption Scenario
  • SELECT LICENSE :

  • US$5,000
  • US$7,500
  • US$10,000

General Anesthesia Drugs: Moving Beyond Traditional Anesthetic Techniques

Advances in technologies and assays have been opening new avenues in drug discovery, creating opportunities to study complex disease mechanisms and find cures for the indications. As numerous developments were brought to drug discovery process as well as surgical interventions, the importance of general anesthesia drugs has moved from merely putting patients to sleep in operating rooms to delivering best possible pre-, intra-, and postoperative care to meet the needs of patients undergoing major surgery. Over the years, from ether to Propofol, newer range of anesthetic drugs with fewer side effects came in to use in a number of operational procedures. Moreover, technological changes in anesthesiology and its practice including ‘robotic’ anesthesia and ‘tele’ anesthesia have been offering the possibility of distant preoperative assessment of the patient’s fitness for specific anesthesia drug and the control of its delivery. While highly specific and target oriented technologies have reduced the anesthesia-associated mortality and morbidity, advances in cell biology, genetics, and molecular biology have spurred the development of better anesthetic drugs with minimal or no complication. An increase in global volume of surgical activities as a result of aging population growth and high prevalence of cardiovascular diseases has worked in tandem with rising demand for general anesthesia drugs.

Surgical Complexities and Patient Safety Expectations to Drive New Developments

The migration of health care systems from ‘fee-for-service (FFS)’ to ‘pay-for-performance (P4P)’ models have been forcing the healthcare professionals to reevaluate how they approach the delivery of care. Over the years, a large number of intravenous and inhalation agents of general anesthesia drugs have been introduced, and in parallel various drugs have undergone clinical usage and then withdrawn when found unreliable. The development of safer drugs were propelled by increasing surgical complexity and severity of patient illness along with growing expectations of patient safety. As general anesthesia drugs are commonly associated with several side effects, manufacturers are directing their investments towards the development of new formulations of existing agents or entirely new chemical entities in strides to improve safety, efficacy, recovery profile, and minimize side effects. Considering the nature of the product, manufacturers are constantly focusing on keeping up with several regulations and guidelines on general anesthesia drugs which have been revised and updated to improve procedural safety and efficacy. Although the robotic or minimally invasive surgeries have significantly transformed the operational procedures, these processes can take longer than open surgery which may increase the possible risks of anesthesia, thereby compelling manufacturers to innovate their products with reduced side effects.

The U.S. Takes the Center Stage

Despite many advancements in anesthesia techniques and availability of newer and safer drugs, much more scientific exploration and large clinical trials are needed to provide the greatest level of evidence and safety, prior to widespread clinical implementation. Growth prospects of the general anesthesia drugs market are relatively high in the U.S., driven by increasing risk of organ failures and cardiac diseases among baby boomers along with significant restructuring of the healthcare system in the country. Rapid adoption of innovative business models focused on novel strategies such as seeking faster approval of drugs for reduced time-to-market and more reliance on external partners, academia, and industry consortia will continue to favor the manufacturers operating in the nation.

* This data is only a representation. Actual data may vary and will be available in report.

The U.S. Takes the Center Stage
The U.S. Takes the Center Stage
The U.S. Takes the Center Stage
The U.S. Takes the Center Stage
  • 2014
  • 2018
  • 2022
  • 2029
  • Arrow

Tracking the Lasting Effects of General Anesthesia Drugs on Human Health

Although the introduction of general anesthesia drugs dates back to 1840s, they continue to associate with several side effects including elevation in blood pressure and heart rate, respiratory depression, amnesia, and even hallucinations. For example, opioid-containing anesthesia has been linked with post-surgery nausea, vomiting, and drowsiness that can hinder the patient’s recovery. A focus on opioid-free general anesthesia, aligning with clinical strategies that include the use of multimodal analgesia and enhanced recovery after surgery (ERAS) initiatives, has been making a headway in reducing the use of addictive medications prior to surgical interventions. Modern general anesthesia drugs have not only enabled complex surgical procedures to be performed safely on patients but also has significantly advanced human medicine. However, several studies regarding the impact of general anesthesia drugs on human health are still underway. The jury is still out as a new Israeli study links child born via C-section under general anesthesia with the risk of developing autism, while another study claims that general anesthesia in infancy has no detectable impact on brain development.

Propofol remains the top-selling category

Sevoflurane to witness high adoption

 

General Anesthesia Drugs Market Analysis

Intravenous administration remains highly preferred

Administration through inhalation gains momentum

General Anesthesia Drugs Market Analysis

Hospitals remain the top end user

Use in ambulatory surgical centers grows rapidly

General Anesthesia Drugs Market Analysis

How Growth will Unfold

While various clinical trials are underway to unfold the possible impacts of general anesthesia drugs on both adult and pediatric health, manufacturers are largely engaged in entering into strategic collaboration with research institutes for the development of innovative solutions. As the developing and aging brain may be vulnerable to general anesthesia drugs, manufacturers are directing towards the development of drugs and routes of administration with faster and predictable effects with easy reversibility of action and lesser side effects profiles. Further, leveraging advancements in novel drug delivery systems and monitoring equipment making anesthetic practice faster, simpler, and safer will remain a key focus area of the market players.

General Anesthesia Drugs Market Analysis

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Read in-depth analysis on General Anesthesia Drugs Consumption Scenario

Overview

General Anesthesia Drugs Market Analysis 2019 - 2029

A recent market study published by FMI on the general anesthesia drugs market during 2014-2018 & forecast for 2019-2029 offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the general anesthesia drugs market, the growth prospects of the market have been obtained with maximum precision.

General Anesthesia Drugs Market Taxonomy

The global general anesthesia drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Drug Class

  • Propofol
  • Sevoflurane
  • Dexmedetomidine
  • Desflurane
  • Remifentanil
  • Midazolam
  • Others
  • (Others – Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental etc.)

By Route of Administration

  • Intravenous Anesthesia
  • Inhaled Anesthesia

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

What's Included

The report commences with the executive summary of the general anesthesia drugs market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the general anesthesia drugs market.

Readers can find the detailed taxonomy and the definition of the general anesthesia drugs market in this chapter, which will help them understand the basic information about the general anesthesia drugs market.

The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market developments and product innovations.

This section explain the global market value analysis and forecast for the general anesthesia drugs market between the forecast periods of 2014-2029. This chapter includes the detailed analysis of the historical general anesthesia drugs market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 – 2020), and an incremental opportunity for the forecast period (2019 – 2029).

This chapter explains the key macro-economic factors that are expected to influence the growth of the general anesthesia drugs market over the forecast period. Along with macro-economic factors, this section also highlights the opportunity analysis for the general anesthesia drugs market. Moreover, this chapter highlights the key market dynamics of the general anesthesia drugs market, which include the drivers, restraints, and trends. Readers can also find the key success factors in the general anesthesia drugs market.

Based on drug class, the general anesthesia drugs market is segmented into Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam and others such as Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental, etc. In this chapter, readers can find information about the year-on-year growth in the general anesthesia drugs market and market attractiveness analysis based on the drug class.

Based on the route of administration, the general anesthesia drugs market is segmented as intravenous anesthesia and inhaled anesthesia. In this chapter, readers can find information about the year on year growth in the general anesthesia drugs market and market attractiveness analysis based on the route of administration.

This chapter provides details about the general anesthesia drugs market on the basis of end user, and has been classified into hospitals, specialty clinics, and ambulatory surgical centers. In this chapter, readers can understand the market attractive analysis based on the end user.

This chapter explains how the general anesthesia drugs market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).

This chapter includes a detailed analysis of the growth of the North America general anesthesia drugs market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the impact analysis of the drivers and restraints of the general anesthesia drugs market in North America.

Readers can find detailed information about the regional trends, which are impacting the growth of the Latin America general anesthesia drugs market. This chapter also includes the growth prospects of the general anesthesia drugs market in the leading LATAM countries such as Brazil, Mexico, Argentina, and the Rest of Latin America.

Important growth prospects of the general anesthesia drugs market based on its distribution channel in several countries, such as Germany, the UK, France, Spain, Italy, Russia, and the Rest of Europe, are included in this chapter.

India, Indonesia, Thailand, and Malaysia are the leading countries in the South Asia region, which are the prime subjects of assessment to obtain the growth prospects of the South Asia general anesthesia drugs market in this chapter. Readers can find detailed information about the growth parameters of the South Asia general anesthesia drugs market during the period 2019-2029.

This chapter highlights the growth of the general anesthesia drugs market in East Asia by focusing on China, Japan, and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the general anesthesia drugs market in East Asia.

In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania general anesthesia drugs market.

This chapter provides information about how the general anesthesia drugs market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, and the rest of MEA, during the forecast period 2019 - 2029.

This chapter provides information about how the general anesthesia drugs market will grow in Brazil during the forecast period 2019 - 2029.

This chapter highlights the growth of the general anesthesia drugs market in China during the forecast period 2019 - 2029.

This chapter includes a detailed analysis of the growth of the India general anesthesia drugs market during the forecast period 2019 - 2029.

This chapter includes the following forecast factors:
Increasing number of surgeries
New anesthesia drug approvals
R&D investment by major players

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the general anesthesia drugs report.

This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the general anesthesia drugs market.

How the research was conducted?

Primary Research

  • C - Level Executives
  • Marketing Directors
  • Sales Heads
  • Portfolio Managers
  • Purchasing Managers
  • Medical Officers
  • Strategy Advisors
  • R&D Managers
  • Product Manufacturers
  • Distributors
  • Pharmacists / Pharmacy Benefit Managers
  • Hospital Purchasing Departments
  • Physicians / Nursing Managers
  • Industry Experts
  • Current Market Dynamics and Challenges
  • Market Characteristics
  • Market Performance and Growth Quadrants
  • Competition Structure and Market Structure
  • Strategic Growth Initiatives
  • Disease Patterns, Treatment and Prescription Patterns
  • Regulatory and Reimbursement Landscape
  • Products in Pipeline and Clinical Development
  • Near-term and Long-term Market Growth Prospects
  • Market Segment Splits and Authenticity
  • Opinions on Market Projections and Validity of Assumptions

Secondary Research

  • Industry Magazines
  • Association of Anesthetists
  • American Society of Anesthesiologists 
  • Company Press Releases
  • Annual Reports and Investor Presentations
  • Peer-reviewed Journals
  • Government Websites and Publications
  • Trade Websites
  • Clinical Trial Registries
  • Country-specific Regulatory Authorities
  • World Bank, WHO

Primary Interview Splits

Primary Interview Splits general anesthesia drugs market split by designation

Primary Interview Splits general anesthesia drugs market split by stakeholders

General Anesthesia Drugs Market Reports - Table of Contents

Figure 01: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 02: Global General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 03: Global General Anesthesia Drugs Market Absolute $ Opportunity, 2019–2029

Figure 04: General Anesthesia Drugs Market Forecast Factors – Relevance and Impact

Figure 05: Global General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 06: Global General Anesthesia Drugs Market Y-o-Y Growth Projections by Product Type, 2019 – 2029

Figure 07: Global General Anesthesia Drugs Market Analysis by Product type–2019 & 2029

Figure 08: Global General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 09: Global General Anesthesia Drugs Market Y-o-Y Growth Projections Route of Administration, 2019 – 2029

Figure 10: Global General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 11: Global General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 12: Global General Anesthesia Drugs Market Y-o-Y Growth Projections End User, 2019 – 2029

Figure 13: Global General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 14: Global General Anesthesia Drugs Market Analysis by Region–2019 & 2029

Figure 15: Global General Anesthesia Drugs Market Y-o-Y Growth Projections Region, 2019 – 2029

Figure 16: Global General Anesthesia Drugs Market Analysis by Region–2019 & 2029

Figure 17: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 18: North America General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 19: North America General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 20: North America General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 21: North America General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 22: North America General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 23: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 24: Latin America General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 25: Latin America General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 26: Latin America General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 27: Latin America General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 28: Latin America General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 29: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 30: Europe General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 31: Europe General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 32: Europe General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 33: Europe General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 34: Europe General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 35: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 36: South Asia General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 37: South Asia General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 38: South Asia General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 39: South Asia General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 40: South Asia General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 41: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 42: East Asia General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 43: East Asia General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 44: East Asia General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 45: East Asia General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 46: East Asia General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 47: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 48: Oceania General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 49: Oceania General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 50: Oceania General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 51: Oceania General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 52: Oceania General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 53: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 54: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 55: Middle East and Africa General Anesthesia Drugs Market Analysis by Country–2019 & 2029

Figure 56: Middle East and Africa General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 57: Middle East and Africa General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 58: Middle East and Africa General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 59: Emerging Countries Market Value Share (2019) 

Figure 60: Emerging Countries General Anesthesia Drugs Market Value (US$ Mn), By Key Countries, 2019-2029

Figure 61: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 62: Brazil  General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 63: Brazil  General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 64: Brazil  General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 65: Brazil General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 66: China General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 67: China General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 68: China General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 69: China General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 70: China General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Figure 71: India General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018

Figure 72: India General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 73: India General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029

Figure 74: India General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029

Figure 75: India General Anesthesia Drugs Market Analysis by End User–2019 & 2029

Table 01: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 02: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 03: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 04: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region

Table 05: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 06: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 07: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 08: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 09: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 10: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 11: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 12: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 13: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 14: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 15: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 16: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 17: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 18: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 19: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 20: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 21: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 22: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 23: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 24: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 25: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 26: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 27: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 28: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 29: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 30: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 31: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 32: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 33: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 34: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 35: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 36: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 37: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 38: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 39: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 40: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration

Table 41: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

To Learn More About our Comprehensive Perspective on General Anesthesia Drugs Consumption Scenario, Contact Us

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Client Partner - Global Business Development

* indicates mandatory fields

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology